Hanahan and Weinberg 2022 Cancer Hallmarks Framework
The 2022 Hanahan update expands the cancer hallmarks framework to include phenotypic plasticity and disrupted differentiation as a discrete hallmark capability, plus two new enabling characteristics: nonmutational epigenetic reprogramming and polymorphic microbiomes, while also recognizing senescent cells as functionally important components of the tumor microenvironment 1.
Core Framework Evolution
The 2022 revision builds upon the original conceptualization by adding critical dimensions that reflect our evolved understanding of cancer biology:
New Hallmark Capability
- Phenotypic plasticity and disrupted differentiation: This represents the ability of cancer cells to dedifferentiate, transdifferentiate, or maintain stem-like states, enabling adaptation to therapeutic pressures and microenvironmental changes 1
New Enabling Characteristics
Nonmutational epigenetic reprogramming functions as a distinct mechanism facilitating hallmark acquisition without requiring genetic mutations. This includes:
- DNA methylation changes
- Histone modifications
- Chromatin remodeling alterations
- These changes can be reversible yet heritable through cell divisions 1
Polymorphic microbiomes constitute the second new enabling characteristic, recognizing that:
- Intratumoral and gut microbiomes influence cancer development
- Microbial communities modulate immune responses
- Bacterial metabolites affect therapeutic efficacy
- Microbiome composition varies between patients and tumor types 1
Expanded Tumor Microenvironment
Senescent cells are now formally recognized as functionally important cell types within the tumor microenvironment, joining cancer-associated fibroblasts, immune cells, and vascular components. Senescent cells contribute through:
- Secretion of inflammatory cytokines (SASP - senescence-associated secretory phenotype)
- Promotion of tumor growth and invasion
- Modulation of immune surveillance 1
Integration with Complexity Theory
The 2022 framework acknowledges that cancer operates as a complex adaptive system rather than a simple linear progression. This perspective emphasizes:
- Nonlinearity: Small molecular changes can produce disproportionate phenotypic effects
- Emergence: Tumor behaviors arise from interactions that cannot be predicted from individual components alone
- Feedback loops: Bidirectional communication between tumor cells and microenvironment
- Historical dependence: Prior exposures and evolutionary trajectories shape current tumor behavior 2
Clinical Implications
This expanded framework provides multiple therapeutic intervention points:
- Targeting phenotypic plasticity to prevent treatment resistance
- Modulating epigenetic programs without requiring genetic targeting
- Manipulating microbiome composition to enhance treatment efficacy
- Eliminating senescent cells (senolytic therapy) to reduce pro-tumorigenic signaling 1, 2
Important Caveats
The 2022 hallmarks remain a heuristic tool rather than a complete mechanistic description. The framework intentionally simplifies cancer's vast complexity into manageable conceptual categories. Not every cancer will manifest all hallmarks equally, and the temporal sequence of hallmark acquisition varies by tumor type and individual patient 1.
The integration of these new dimensions reflects technological advances in single-cell sequencing, spatial transcriptomics, and microbiome analysis that were unavailable during earlier iterations of the framework 3.